Literature DB >> 10084699

Immunostimulatory properties of genomic DNA from different bacterial species.

D C Neujahr1, C F Reich, D S Pisetsky.   

Abstract

Bacterial DNA has potent immunological properties because of its content of immunostimulatory sequences centering on CpG motifs. To investigate whether DNA from various bacterial species differ in these properties, the activity of a panel of DNA was assessed in in vitro cultures of murine spleen cells. This panel varied in base composition and included DNA from Clostridium perfringens (CP), Escherichia coli (EC), Micrococcus lysodeikticus (MC), Staphylococcus aureus (SA), and, as a mammalian DNA control, calf thymus (CT) DNA. In assays of IL-12 and IFN-gamma production as well as B cell mitogenesis, these DNA showed marked differences in their immunostimulatory activity. For both cytokine and B cell responses, EC DNA demonstrated the highest activity while CP DNA had the lowest activity among the bacterial DNA. To determine whether differences in stimulatory capacity resulted from differences in cell uptake, the activity of DNA complexed with lipofectin was tested. While the addition of lipofectin to DNA increased stimulation by all DNA, it did not change the relative potency of the DNA tested. These results indicate that bacterial DNA differ in their immunostimulatory capacity, most likely reflecting their content of CpG motifs. These differences could affect the induction of innate immunity as well as the consequences of infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084699     DOI: 10.1016/S0171-2985(99)80036-9

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

Review 1.  Mechanisms of immune stimulation by bacterial DNA.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

2.  TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae.

Authors:  Katherine S Lee; Charles A Scanga; Eric M Bachelder; Quanyi Chen; Clifford M Snapper
Journal:  Cell Immunol       Date:  2007-05-22       Impact factor: 4.868

3.  Characterization of immunostimulatory CpG-rich sequences from different Bifidobacterium species.

Authors:  Odile Ménard; Valérie Gafa; Nathalie Kapel; Bertrand Rodriguez; Marie-José Butel; Anne-Judith Waligora-Dupriet
Journal:  Appl Environ Microbiol       Date:  2010-03-05       Impact factor: 4.792

4.  Activation of toll-like receptor 9 by DNA from different bacterial species.

Authors:  Alexander Dalpke; Jutta Frank; Mirjam Peter; Klaus Heeg
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 5.  Recognition of Staphylococcus aureus by the innate immune system.

Authors:  Bénédicte Fournier; Dana J Philpott
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase.

Authors:  Martin A Taubman; Xiaozhe Han; Karen B Larosa; Sigmund S Socransky; Daniel J Smith
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

7.  Truncated human cytidylate-phosphate-deoxyguanylate-binding protein for improved nucleic acid amplification technique-based detection of bacterial species in human samples.

Authors:  Svea Sachse; Eberhard Straube; Marc Lehmann; Michael Bauer; Stefan Russwurm; Karl-Hermann Schmidt
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

8.  Regulatory role of suppressive motifs from commensal DNA.

Authors:  N Bouladoux; J A Hall; J R Grainger; L M dos Santos; M G Kann; V Nagarajan; D Verthelyi; Y Belkaid
Journal:  Mucosal Immunol       Date:  2012-05-23       Impact factor: 7.313

9.  Molecular evidence supporting Ehrlichia canis-like infection in cats.

Authors:  Edward B Breitschwerdt; Anthony C G Abrams-Ogg; Michael R Lappin; Dorothee Bienzle; Susan I Hancock; Sara M Cowan; Jennifer K Clooten; Barbara C Hegarty; Eleanor C Hawkins
Journal:  J Vet Intern Med       Date:  2002 Nov-Dec       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.